The scar is elevated above the skin and remains hyperemic. Excessive fibrous tissue is classified as either a keloid or a hypertrophic scar. Kischer and Brody declared the collagen nodule to be the identifying structural unit of hypertrophic scars and keloids.
This report contains market size and forecasts of Hypertrophic and Keloid Scar Therapy in global, including the following market information:
Global Hypertrophic and Keloid Scar Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hypertrophic and Keloid Scar Therapy Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Hypertrophic and Keloid Scar Therapy companies in 2021 (%)
The global Hypertrophic and Keloid Scar Therapy market was valued at 6990.6 million in 2021 and is projected to reach US$ 11380 million by 2028, at a CAGR of 7.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Topical Products Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hypertrophic and Keloid Scar Therapy include Smith & Nephew, Enaltus, Merz, Lumenis, Sonoma Pharmaceuticals, Cynosure, Scar Heal, Mölnlycke Health and Perrigo, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hypertrophic and Keloid Scar Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hypertrophic and Keloid Scar Therapy Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hypertrophic and Keloid Scar Therapy Market Segment Percentages, by Type, 2021 (%)
Topical Products
Laser Products
Injectable
Others
Global Hypertrophic and Keloid Scar Therapy Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hypertrophic and Keloid Scar Therapy Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Hypertrophic and Keloid Scar Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hypertrophic and Keloid Scar Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hypertrophic and Keloid Scar Therapy revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hypertrophic and Keloid Scar Therapy revenues share in global market, 2021 (%)
Key companies Hypertrophic and Keloid Scar Therapy sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Hypertrophic and Keloid Scar Therapy sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Smith & Nephew
Enaltus
Merz
Lumenis
Sonoma Pharmaceuticals
Cynosure
Scar Heal
Mölnlycke Health
Perrigo
NewMedical Technology
Suneva Medical
Pacific World